Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
09/2005
09/21/2005CN1219531C A medicine for treating bed-sore and method for preparing same
09/21/2005CN1219526C Chinese medicine for bone-setting and method for preparing same
09/21/2005CN1219525C Chinese medicine for treating women's ovary cancer and uterine myoma
09/21/2005CN1219524C Medicine for treating femoral head necrosis and its preparation method
09/21/2005CN1219521C A scar-removing acne-controlling formulation and preparation method
09/21/2005CN1219516C Medical use of 11, 11'-dideoxy wotixilin
09/20/2005US6946133 Prostate specific antigen oligo-epitope peptide
09/20/2005US6946132 Pure dnaJp1 peptide in a carrier; dnaJ is a heat shock protein; also immunoassay for identifying persons who are predisposed to develop rheumatoid arthritis
09/20/2005US6946127 Block exposure to nerve toxicity
09/20/2005US6945247 Method of treating cardio pulmonary diseases with no group compounds
09/20/2005CA2189882C Papillomavirus vaccines
09/18/2005CA2461241A1 Chemical dissociation of cell aggregates
09/15/2005WO2005085429A1 Reverse-flow perfusioin of three-dimensional scaffolds
09/15/2005WO2005085424A2 Endothelial progenitor cells and methods of use thereof
09/15/2005WO2005085423A1 Oct-4 and gjic expression as markers for adult human stem cells and cancer cell precursors
09/15/2005WO2005085422A1 Adult stem cells and uses thereof
09/15/2005WO2005085421A2 Treatment of spinal conditions
09/15/2005WO2005085418A1 Novel lactic acid bacterium
09/15/2005WO2005084725A1 Compositions for repairing bone and methods for preparing and using such compositions
09/15/2005WO2005084691A1 Method of proliferating precursor cells
09/15/2005WO2005084646A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
09/15/2005WO2005084463A1 Aggregates of eyeballs of crustaceans, usage, foods coataining the same, and production processes
09/15/2005WO2005060709A3 Methods of use of probiotic bifidobacteria for companion animals
09/15/2005WO2005052140A3 Multipotent postnatal stem cells from human periodontal ligament and uses thereof
09/15/2005WO2005047491A3 Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy
09/15/2005WO2005047458A3 Modified recombinant vaccina viruses and other microorganisms, uses thereof
09/15/2005WO2005039606A3 Moderating the effect of endotoxins
09/15/2005WO2005038012A3 Cartilage and bone repair and regeneration using postpartum-derived cells
09/15/2005WO2005009450A3 Use of botulinum toxin for producing drug for preventing or treating final phase of lung troubles
09/15/2005WO2004110372A3 Room temperature storage of organs
09/15/2005WO2004050832A3 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens
09/15/2005US20050204412 Artery- and vein-specific proteins and uses therefor
09/15/2005US20050204406 Expression vector comprising nucleotide sequences coding blood coagulation factor for use as heterologous gene expression tool; treating blood disorders; bioreactor for producing secreted proteins
09/15/2005US20050203057 Treatment of cancers
09/15/2005US20050203008 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
09/15/2005US20050202428 Notch signaling inhibitory RNA sequences for use in treatment and prevention of cell proliferative and developmental disorders
09/15/2005US20050202148 Preparation of microbial oil
09/15/2005US20050202098 Administering leukocytes to suppress immune response; autoimmune diseases; graft versus host disease
09/15/2005US20050202097 Lubricant for the ocular surface
09/15/2005US20050202064 Administering an uronic acid or uronic acid derivative, a saccharide; anticarcinogenic
09/15/2005US20050202058 Cell-seeded extracellular matrix grafts
09/15/2005US20050201997 Dioxin elimination promoter
09/15/2005US20050201996 Administering a probiotic to a household pet; contact dermatitis, actinic dermatitis, dermatitis caused by microbial infection, eczema and rosacea
09/15/2005US20050201992 Culture with human dendritic cells wherein the hybrid cells were generated by fusing tumor cells dissociated from a tumor by mechanical dissociation with a highly enriched population of human B-cells; avoiding the problems of immune suppression, autoimmune reactions, and self-recognition; kits; antitumor
09/15/2005US20050201990 Endothelial progenitor cells and methods of use thereof
09/15/2005US20050201984 An adenoviral genome replaced with a therapeutic gene or DNA sequence regulated by a ubiquitous promoter either a Cytomegalo virus promotor or a tissue-specific phosphoenolpyruvate carboxykinase promoter, where gene or sequence encodes for a latent human metalloprotease gene MMP-8 (collengenases)
09/15/2005US20050201952 Treatment and prevention of viral hepatitis infections
09/15/2005DE102004037184B3 Tissue transplant construct, useful especially for correcting defects in the bladder, comprises collagen-containing membrane supporting layers of organ-specific cells, with the outermost layer fully differentiated
09/15/2005CA2599823A1 Reverse-flow perfusion of three-dimensional scaffolds
09/15/2005CA2559110A1 Endothelial progenitor cells and methods of use thereof
09/15/2005CA2558436A1 Method of proliferating precursor cells
09/15/2005CA2558200A1 Compositions for repairing bone and methods for preparing and using such compositions
09/15/2005CA2558056A1 Treatment of spinal conditions
09/15/2005CA2557876A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
09/15/2005CA2530514A1 Cell therapy formulation method and composition
09/15/2005CA2500926A1 Tumor/b-cell hybrid cells and uses thereof
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1572989A1 Gen 2.2 dendritic cell line
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
09/14/2005EP1572885A2 Methods for treating diabetes and other blood sugar disorders
09/14/2005EP1572879A2 Method of producing region-specific neurons from human neuronal stem cells
09/14/2005EP1572876A2 Transcriptional regulation of target genes
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1572108A2 Functional mutations in respiratory syncytial virus
09/14/2005EP1572089A2 Method for growing human organs, treating diseases, and increasing longevity
09/14/2005EP1572071A2 Systems and methods for treating patients with processed lipoaspirate cells
09/14/2005EP1572069A2 Protective factors against inflammation, burns and noxious stimuli
09/14/2005EP1572064A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration
09/14/2005EP1571910A2 Cytotherapeutics, cytotherapeutic units and methods for treatments using them
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1140009B1 Absorbent article composition and use thereof for sequestering skin irritants.
09/14/2005EP1137422B1 Use of human prostate cell lines for the treatment of prostate cancer
09/14/2005EP1082141B1 Cd40 binding antibodies and ctl peptides for treating tumors
09/14/2005EP1030676B1 Bonding of cartilaginous matrices using isolated chondrocytes
09/14/2005CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
09/14/2005CN1668746A MUC-1 antigen with reduced number of VNTR repeat units
09/14/2005CN1668733A Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
09/14/2005CN1668732A Treatments with autologous fibroblast
09/14/2005CN1668728A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
09/14/2005CN1668631A Fractionation of phytosterol esters in oil
09/14/2005CN1668327A Transdermal botulinum toxin compositions
09/14/2005CN1668324A Methods, compositions, and growth and differentiation factors for insulin-producing cells
09/14/2005CN1668319A Antiflatulent composition, antiflatulent healthy drink and large intestine inside wash fluid
09/14/2005CN1668318A Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
09/14/2005CN1668317A Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
09/14/2005CN1668211A Method for improving immune function in mammals using lactobacillus reuteri strains
09/14/2005CN1667119A Adult stem cell and its culturing method and use
09/14/2005CN1666822A Apparatus for the continuous separation of biological fluids into components and method of using same
09/14/2005CN1666778A Anti-oxidation, anti-senium oyster product and its preparation method
09/14/2005CN1666777A Medicinal preparation of brain protolysate for injection and preparation method thereof
09/14/2005CN1666673A 珍珠饮品原料及其制备方法 Pearl Drinks materials and preparation method
09/14/2005CN1666659A Health food for protecting and improving vision
09/14/2005CN1666654A Preparation method of common house-fly grub freeze-drying nutritious powder
09/14/2005CN1218983C Folic acid-polydiol compound and its medicinal composition
09/14/2005CN1218744C Preparing method of burn and scald treating medicine
09/14/2005CN1218738C Proprietary Chinese internal medicine for promoting blood circulation to stop pain